[Zurück]
 
Bitte auswählen
Jahr
Details
Sprache
Sortierung
Ausgabe
neu: RTF !
 Forschungsbericht für das Jahr 2019

Department Innere Medizin

Klinik für Innere Medizin I

Hugstetter Str. 55
79106 Freiburg
Tel: 0761/270-34060 Fax: 0761/270-32060
https://www.uniklinik-freiburg.de/medizin1.html


Einträge in der Rubrik "Who is Who"

Wissenschaftliche Publikationen

Originalarbeiten in wissenschaftlichen Fachzeitschriften:
  • Asslaber D, Qi Y, Maeding N, Steiner M, Denk U, Hopner JP, Hartmann TN, Zaborsky N, Greil R, Egle A: B-cell specific IRF4 deletion accelerates Chronic Lymphocytic Leukemia development by enhanced tumor immune evasion. Blood, 2019. : http://dx.doi.org/10.1182/blood.2019000973 (in Druck)
  • Becker H, Greve G, Kataoka K, Mallm JP, Duque-Afonso J, Ma T, Niemoller C, Pantic M, Duyster J, Cleary ML, Schuler J, Rippe K, Ogawa S, Lubbert M: Identification of enhancer of mRNA decapping 4 as a novel fusion partner of MLL in acute myeloid leukemia. Blood Advances, 2019; 3 (5): 761-765. : http://dx.doi.org/10.1182/bloodadvances.2018023879
  • Bojtine Kovacs S, Luan J, Dold SM, Weis A, Pantic M, Duyster J, Wasch R, Engelhardt M: Venetoclax in combination with carfilzomib, doxorubicin and dexamethasone restores responsiveness in an otherwise treatment-refractory multiple myeloma patient. Haematologica, 2019. : http://dx.doi.org/10.3324/haematol.2019.232330 (in Druck)
  • Dreger P, Michallet M, Bosman P, Dietrich S, Sobh M, Boumendil A, Nagler A, Scheid C, Cornelissen J, Niederwieser D, Muller L, Vandenberghe E, Scortechini I, Schoemans H, Andersen NS, Finke J, Russo D, Ljungman P, Passweg J, van Gelder M, Durakovic N, Labussiere-Wallet H, Berg T, Wulf G, Bethge W, Bunjes D, Stilgenbauer S, Canepari ME, Schaap M, Fox CP, Kroger N, Montoto S, Schetelig J: Ibrutinib for bridging to allogeneic hematopoietic cell transplantation in patients with chronic lymphocytic leukemia or mantle cell lymphoma: a study by the EBMT Chronic Malignancies and Lymphoma Working Parties. Bone Marrow Transpl, 2019; 54 (1): 44-52. : http://dx.doi.org/10.1038/s41409-018-0207-4
  • Ewerth D, Kreutmair S, Schmidts A, Ihorst G, Follo M, Wider D, Felthaus J, Schuler J, Duyster J, Illert AL, Engelhardt M, Wasch R: APC/C(Cdh1) regulates the balance between maintenance and differentiation of hematopoietic stem and progenitor cells. Cell Mol Life Sci, 2019; 76 (2): 369-380. : http://dx.doi.org/10.1007/s00018-018-2952-3
  • Freihen V, Ronsch K, Mastroianni J, Frey P, Rose K, Boerries M, Zeiser R, Busch H, Hecht A: SNAIL1 employs beta-Catenin-LEF1 complexes to control colorectal cancer cell invasion and proliferation. Int J Cancer, 2019. : http://dx.doi.org/10.1002/ijc.32644 (in Druck)
  • Fuchs S, Sawas N, Staedler N, Schubert DA, D'Andrea A, Zeiser R, Piali L, Hruz P, Frei AP: High-dimensional single-cell proteomics analysis identifies immune checkpoint signatures and therapeutic targets in ulcerative colitis. Eur J Immunol, 2019; 49 (3): 462-475. : http://dx.doi.org/10.1002/eji.201847862
  • Gengenbacher A, Muller-Rudorf A, Poggio T, Grassel L, Dumit VI, Kreutmair S, Lippert LJ, Duyster J, Illert AL: Proteomic Phosphosite Analysis Identified Crucial NPM-ALK-Mediated NIPA Serine and Threonine Residues. Int J Mol Sci, 2019; 20 (16) (online). : http://dx.doi.org/10.3390/ijms20164060
  • Greil C, Engelhardt M, Ihorst G, Schoeller K, Bertz H, Marks R, Zeiser R, Duyster J, Einsele H, Finke J, Wasch R: Allogeneic transplantation of multiple myeloma patients may allow long-term survival in carefully selected patients with acceptable toxicity and preserved quality of life. Haematologica, 2019; 104 (2): 370-379. : http://dx.doi.org/10.3324/haematol.2018.200881
  • Holderried TAW, Fraccaroli A, Schumacher M, Heine A, Brossart P, Stelljes M, Klobuch S, Kroger N, Apostolova P, Finke J, Zeiser R, Heinicke T, Bornhauser M, von Bergwelt-Baildon M, Tischer J, Wolf D: The role of checkpoint blockade after allogeneic stem cell transplantation in diseases other than Hodgkin's Lymphoma. Bone Marrow Transpl, 2019; 54 (10): 1662-1667. : http://dx.doi.org/10.1038/s41409-019-0498-0
  • Hortmann M, Walter JE, Benning L, Follo M, Mayr RM, Honegger U, Robinson S, Stallmann D, Duerschmied D, Twerenbold R, Badertscher P, du Fay de Lavallaz J, Puelacher C, Bode C, Ahrens I, Mueller C: Droplet digital PCR of serum miR-499, miR-21 and miR-208a for the detection of functionally relevant coronary artery disease. Int J Cardiol, 2019; 275: 129-135. : http://dx.doi.org/10.1016/j.ijcard.2018.08.031
  • Hulsdunker J, Thomas OS, Haring E, Unger S, Gonzalo Nunez N, Tugues S, Gao Z, Duquesne S, Cywes-Bentley C, Oyardi O, Kirschnek S, Schmitt-Graeff A, Pabst O, Koenecke C, Duyster J, Apostolova P, Blaser MJ, Becher B, Pier GB, Hacker G, Zeiser R: Immunization against poly-N-acetylglucosamine reduces neutrophil activation and GVHD while sparing microbial diversity. P Natl Acad Sci Usa, 2019; 116 (41): 20700-20706. : http://dx.doi.org/10.1073/pnas.1908549116
  • Jawhar M, Dohner K, Kreil S, Schwaab J, Shoumariyeh K, Meggendorfer M, Span LLF, Fuhrmann S, Naumann N, Horny HP, Sotlar K, Kubuschok B, von Bubnoff N, Spiekermann K, Heuser M, Metzgeroth G, Fabarius A, Klein S, Hofmann WK, Kluin-Nelemans HC, Haferlach T, Dohner H, Cross NCP, Sperr WR, Valent P, Reiter A: KIT D816 mutated/CBF-negative acute myeloid leukemia: a poor-risk subtype associated with systemic mastocytosis. Leukemia, 2019; 33 (5): 1124-1134. : http://dx.doi.org/10.1038/s41375-018-0346-z
  • Jawhar M, Schwaab J, Alvarez-Twose I, Shoumariyeh K, Naumann N, Lubke J, Perkins C, Munoz-Gonzalez JI, Meggendorfer M, Kennedy V, Metzgeroth G, Fabarius A, Pfeifer D, Sotlar K, Horny HP, von Bubnoff N, Haferlach T, Cross NCP, Hofmann WK, Sperr WR, Garcia-Montero AC, Valent P, Gotlib J, Orfao A, Reiter A: MARS: Mutation-Adjusted Risk Score for Advanced Systemic Mastocytosis. J Clin Oncol, 2019; 37 (31): 2846-2856. : http://dx.doi.org/10.1200/JCO.19.00640
  • Koehn BH, Saha A, McDonald-Hyman C, Loschi M, Thangavelu G, Ma L, Zaiken M, Dysthe J, Krepps W, Panthera J, Hippen K, Jameson SC, Miller JS, Cooper MA, Farady CJ, Iwawaki T, Ting JP, Serody JS, Murphy WJ, Hill GR, Murray PJ, Bronte V, Munn DH, Zeiser R, Blazar BR: Danger-associated extracellular ATP counters MDSC therapeutic efficacy in acute GVHD. Blood, 2019; 134 (19): 1670-1682. : http://dx.doi.org/10.1182/blood.2019001950
  • Kohler M, Ehrenfeld S, Halbach S, Lauinger M, Burk U, Reischmann N, Cheng S, Spohr C, Uhl FM, Kohler N, Ringwald K, Braun S, Peters C, Zeiser R, Reinheckel T, Brummer T: B-Raf deficiency impairs tumor initiation and progression in a murine breast cancer model. Oncogene, 2019; 38 (8): 1324-1339. : http://dx.doi.org/10.1038/s41388-018-0663-8
  • Koyama M, Mukhopadhyay P, Schuster IS, Henden AS, Hulsdunker J, Varelias A, Vetizou M, Kuns RD, Robb RJ, Zhang P, Blazar BR, Thomas R, Begun J, Waddell N, Trinchieri G, Zeiser R, Clouston AD, Degli-Esposti MA, Hill GR: MHC Class II Antigen Presentation by the Intestinal Epithelium Initiates Graft-versus-Host Disease and Is Influenced by the Microbiota. Immunity, 2019. : http://dx.doi.org/10.1016/j.immuni.2019.08.011 (in Druck)
  • Kurtz DM, Esfahani MS, Scherer F, Soo J, Jin MC, Liu CL, Newman AM, Duhrsen U, Huttmann A, Casasnovas O, Westin JR, Ritgen M, Bottcher S, Langerak AW, Roschewski M, Wilson WH, Gaidano G, Rossi D, Bahlo J, Hallek M, Tibshirani R, Diehn M, Alizadeh AA: Dynamic Risk Profiling Using Serial Tumor Biomarkers for Personalized Outcome Prediction. Cell, 2019; 178 (3): 699-713.e19. : http://dx.doi.org/10.1016/j.cell.2019.06.011
  • Lee CJ, Labopin M, Beelen D, Finke J, Blaise D, Ganser A, Itala-Remes M, Chevallier P, Labussiere-Wallet H, Maertens J, Yakoub-Agha I, Bourhis JH, Mailhol A, Mohty M, Savani BN, Nagler A: Comparative outcomes of myeloablative and reduced-intensity conditioning allogeneic hematopoietic cell transplantation for therapy-related acute myeloid leukemia with prior solid tumor: A report from the acute leukemia working party of the European society for blood and bone marrow transplantation. Am J Hematol, 2019; 94 (4): 431-438. : http://dx.doi.org/10.1002/ajh.25395
  • Lin CH, Wang Z, Duque-Afonso J, Wong SH, Demeter J, Loktev AV, Somervaille TCP, Jackson PK, Cleary ML: Oligomeric self-association contributes to E2A-PBX1-mediated oncogenesis. Sci Rep-uk, 2019; 9 (1): 4915-4915. : http://dx.doi.org/10.1038/s41598-019-41393-w
  • Mastroianni J, Stickel N, Andrlova H, Hanke K, Melchinger W, Duquesne S, Schmidt D, Falk M, Andrieux G, Pfeifer D, Dierbach H, Schmitt-Graeff A, Meiss F, Boerries M, Zeiser R: miR-146a controls immune response in the melanoma microenvironment. Cancer Res, 2019; 79 (1): 183-195. : http://dx.doi.org/10.1158/0008-5472.CAN-18-1397
  • Newman AM, Steen CB, Liu CL, Gentles AJ, Chaudhuri AA, Scherer F, Khodadoust MS, Esfahani MS, Luca BA, Steiner D, Diehn M, Alizadeh AA: Determining cell type abundance and expression from bulk tissues with digital cytometry. Nat Biotechnol, 2019; 37 (7): 773-782. : http://dx.doi.org/10.1038/s41587-019-0114-2
  • Noviello M, Manfredi F, Ruggiero E, Perini T, Oliveira G, Cortesi F, De Simone P, Toffalori C, Gambacorta V, Greco R, Peccatori J, Casucci M, Casorati G, Dellabona P, Onozawa M, Teshima T, Griffioen M, Halkes CJM, Falkenburg JHF, Stolzel F, Altmann H, Bornhauser M, Waterhouse M, Zeiser R, Finke J, Cieri N, Bondanza A, Vago L, Ciceri F, Bonini C: Bone marrow central memory and memory stem T-cell exhaustion in AML patients relapsing after HSCT. Nat Commun, 2019; 10 (1): 1065-1065. : http://dx.doi.org/10.1038/s41467-019-08871-1
  • O'Connor T, Zhou X, Kosla J, Adili A, Garcia Beccaria M, Kotsiliti E, Pfister D, Johlke AL, Sinha A, Sankowski R, Schick M, Lewis R, Dokalis N, Seubert B, Hochst B, Inverso D, Heide D, Zhang W, Weihrich P, Manske K, Wohlleber D, Anton M, Hoellein A, Seleznik G, Bremer J, Bleul S, Augustin HG, Scherer F, Koedel U, Weber A, Protzer U, Forster R, Wirth T, Aguzzi A, Meissner F, Prinz M, Baumann B, Hopken UE, Knolle PA, von Baumgarten L, Keller U, Heikenwalder M: Age-Related Gliosis Promotes Central Nervous System Lymphoma through CCL19-Mediated Tumor Cell Retention. Cancer Cell, 2019; 36 (3): 250-267.e9. : http://dx.doi.org/10.1016/j.ccell.2019.08.001
  • Paczulla AM, Rothfelder K, Raffel S, Konantz M, Steinbacher J, Wang H, Tandler C, Mbarga M, Schaefer T, Falcone M, Nievergall E, Dorfel D, Hanns P, Passweg JR, Lutz C, Schwaller J, Zeiser R, Blazar BR, Caligiuri MA, Dirnhofer S, Lundberg P, Kanz L, Quintanilla-Martinez L, Steinle A, Trumpp A, Salih HR, Lengerke C: Publisher Correction: Absence of NKG2D ligands defines leukaemia stem cells and mediates their immune evasion. Nature, 2019; 572 (7770): E19-E19. : http://dx.doi.org/10.1038/s41586-019-1475-x
  • Paczulla AM, Rothfelder K, Raffel S, Konantz M, Steinbacher J, Wang H, Tandler C, Mbarga M, Schaefer T, Falcone M, Nievergall E, Dorfel D, Hanns P, Passweg JR, Lutz C, Schwaller J, Zeiser R, Blazar BR, Caligiuri MA, Dirnhofer S, Lundberg P, Kanz L, Quintanilla-Martinez L, Steinle A, Trumpp A, Salih HR, Lengerke C: Absence of NKG2D ligands defines leukaemia stem cells and mediates their immune evasion. Nature, 2019; 572 (7768): 254-259. : http://dx.doi.org/10.1038/s41586-019-1410-1
  • Pantic M, Pfeifer D, Kapp-Schwoerer S, Ihorst G, Becker H, Zeiser R, Duyster J, Schmitt-Graeff A: TP53 abnormalities and chromosomal aneuploidy in acute panmyelosis with myelofibrosis. Leukemia, 2019. : http://dx.doi.org/10.1038/s41375-019-0523-8 (in Druck)
  • Reinhardt H, Otte P, Eggleton AG, Ruch M, Wohrl S, Ajayi S, Duyster J, Jung M, Hug MJ, Engelhardt M: Avoiding chemotherapy prescribing errors: Analysis and innovative strategies. Cancer Cytopathol, 2019; 125 (9): 1547-1557. : http://dx.doi.org/10.1002/cncr.31950
  • Robin M, Porcher R, Ruggeri A, Blaise D, Wolschke C, Koster L, Angelucci E, Stolzel F, Potter V, Yakoub-Agha I, Koc Y, Ciceri F, Finke J, Labussiere-Wallet H, Cascon MJP, Verbeek M, Rambaldi A, Cornelissen JJ, Chevallier P, Radia R, Nagler A, Fegueux N, Gluckman E, de Witte T, Kroger N: HLA-Mismatched Donors in Patients with Myelodysplastic Syndrome: An EBMT Registry Analysis. Biol Blood Marrow Tr, 2019; 25 (1): 114-120. : http://dx.doi.org/10.1016/j.bbmt.2018.08.026
  • Rudorf A, Muller TA, Klingeberg C, Kreutmair S, Poggio T, Gorantla SP, Ruckert T, Schmitt-Graeff A, Gengenbacher A, Paschka P, Baldus C, Zeiser R, Vassiliou GS, Bradley A, Duyster J, Illert AL: NPM1c alters FLT3-D835Y localization and signaling in acute myeloid leukemia. Blood, 2019; 134 (4): 383-388. : http://dx.doi.org/10.1182/blood.2018883140
  • Saha A, Taylor PA, Lees CJ, Panoskaltsis-Mortari A, Osborn MJ, Feser CJ, Thangavelu G, Melchinger W, Refaeli Y, Hill GR, Munn DH, Murphy WJ, Serody JS, Maillard I, Kreymborg K, van den Brink M, Dong C, Huang S, Zang X, Allison JP, Zeiser R, Blazar BR: Donor and host B7-H4 expression negatively regulates acute graft-versus-host disease lethality. JCI Insight, 2019; 4 (19) (online). : http://dx.doi.org/10.1172/jci.insight.127716
  • Saussele S, Haverkamp W, Lang F, Koschmieder S, Kiani A, Jentsch-Ullrich K, Stegelmann F, Pfeifer H, La Rosee P, Goekbuget N, Rieger C, Waller CF, Franke GN, le Coutre P, Kirchmair R, Junghanss C: Ponatinib in the Treatment of Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Leukemia: Recommendations of a German Expert Consensus Panel with Focus on Cardiovascular Management. Acta Haematol-basel, 2019: 1-15. : http://dx.doi.org/10.1159/000501927 (in Druck)
  • Schafer AK, Waterhouse M, Follo M, Duque-Afonso J, Duyster J, Bertz H, Finke J: Phenotypical and functional analysis of donor lymphocyte infusion products after Transfus Apher Sci, 2019. : http://dx.doi.org/10.1016/j.transci.2019.06.022 (in Druck)
  • Schetelig J, de Wreede LC, van Gelder M, Koster L, Finke J, Niederwieser D, Beelen D, Mufti GJ, Platzbecker U, Ganser A, Heidenreich S, Maertens J, Socie G, Brecht A, Stelljes M, Kobbe G, Volin L, Nagler A, Vitek A, Luft T, Ljungman P, Yakoub-Agha I, Robin M, Kroger N: Late treatment-related mortality versus competing causes of death after allogeneic transplantation for myelodysplastic syndromes and secondary acute myeloid leukemia. Leukemia, 2019; 33 (3): 686-695. : http://dx.doi.org/10.1038/s41375-018-0302-y
  • Schmid C, Labopin M, Schaap N, Veelken H, Schleuning M, Stadler M, Finke J, Hurst E, Baron F, Ringden O, Bug G, Blaise D, Tischer J, Bloor A, Esteve J, Giebel S, Savani B, Gorin NC, Ciceri F, Mohty M, Nagler A: Prophylactic donor lymphocyte infusion after allogeneic stem cell transplantation in acute leukaemia - a matched pair analysis by the Acute Leukaemia Working Party of EBMT. Brit J Haematol, 2019; 184 (5): 782-787. : http://dx.doi.org/10.1111/bjh.15691
  • Schmitt AM, Herbrand AK, Fox CP, Bakunina K, Bromberg JEC, Cwynarski K, Doorduijn JK, Ferreri AJM, Illerhaus G, Issa S, Schorb E, Zucca E, Hemkens LG, Schandelmaier S, Kasenda B: Rituximab in primary central nervous system lymphoma-A systematic review and Hematol Oncol, 2019. : http://dx.doi.org/10.1002/hon.2666 (in Druck)
  • Schorb E, Finke J, Ihorst G, Kasenda B, Fricker H, Illerhaus G: Age-adjusted high-dose chemotherapy and autologous stem cell transplant in elderly and fit primary CNS lymphoma patients. Bmc Cancer, 2019; 19 (1): 287-287. : http://dx.doi.org/10.1186/s12885-019-5473-z
  • Schorb E, Illerhaus G, Finke J: [Current Treatment Standards in PCNSL]. Deut Med Wochenschr, 2019; 144 (3): 161-164. : http://dx.doi.org/10.1055/a-0601-0992
  • Sperr WR, Kundi M, Alvarez-Twose I, van Anrooij B, Oude Elberink JNG, Gorska A, Niedoszytko M, Gleixner KV, Hadzijusufovic E, Zanotti R, Bonadonna P, Bonifacio M, Perkins C, Illerhaus A, Elena C, Merante S, Shoumariyeh K, von Bubnoff N, Parente R, Jawhar M, Belloni Fortina A, Caroppo F, Brockow K, Zink A, Fuchs D, Kilbertus AJ, Yavuz AS, Doubek M, Hagglund H, Panse J, Sabato V, Bretterklieber A, Niederwieser D, Breynaert C, Hartmann K, Triggiani M, Nedoszytko B, Reiter A, Orfao A, Hermine O, Gotlib J, Arock M, Kluin-Nelemans HC, Valent P: International prognostic scoring system for mastocytosis (IPSM): a retrospective cohort study. Lancet Haematol, 2019. : http://dx.doi.org/10.1016/S2352-3026(19)30166-8 (in Druck)
  • Stomper J, Ihorst G, Suciu S, Sander PN, Becker H, Wijermans PW, Plass C, Weichenhan D, Bisse E, Claus R, Lubbert M: Fetal hemoglobin induction during decitabine treatment of elderly high-risk myelodysplastic syndrome and acute myeloid leukemia patients: a potential dynamic biomarker for outcome. Haematologica, 2019; 104 (1): 59-69. : http://dx.doi.org/10.3324/haematol.2017.187278
  • Thangavelu G, Lee YC, Loschi M, Schaechter KM, Feser CJ, Koehn BH, Nowak EC, Zeiser R, Serody JS, Murphy WJ, Munn DH, Chambon P, Noelle RJ, Blazar BR: Dendritic Cell Expression of Retinal Aldehyde Dehydrogenase-2 Controls Graft-versus-Host Disease Lethality. J Immunol, 2019; 202 (9): 2795-2805. : http://dx.doi.org/10.4049/jimmunol.1800899
  • Toffalori C, Zito L, Gambacorta V, Riba M, Oliveira G, Bucci G, Barcella M, Spinelli O, Greco R, Crucitti L, Cieri N, Noviello M, Manfredi F, Montaldo E, Ostuni R, Naldini MM, Gentner B, Waterhouse M, Zeiser R, Finke J, Hanoun M, Beelen DW, Gojo I, Luznik L, Onozawa M, Teshima T, Devillier R, Blaise D, Halkes CJM, Griffioen M, Carrabba MG, Bernardi M, Peccatori J, Barlassina C, Stupka E, Lazarevic D, Tonon G, Rambaldi A, Cittaro D, Bonini C, Fleischhauer K, Ciceri F, Vago L: Immune signature drives leukemia escape and relapse after hematopoietic cell transplantation. Nat Med, 2019; 25 (4): 603-611. : http://dx.doi.org/10.1038/s41591-019-0400-z
  • Valent P, Oude Elberink JNG, Gorska A, Lange M, Zanotti R, van Anrooij B, Bonifacio M, Bonadonna P, Gleixner KV, Hadzijusufovic E, Perkins C, Hartmann K, Illerhaus A, Merante S, Elena C, Shoumariyeh K, von Bubnoff N, Parente R, Triggiani M, Schwaab J, Jawhar M, Caroppo F, Fortina AB, Brockow K, David Fuchs, Greul R, Yavuz AS, Doubek M, Mattsson M, Hagglund H, Panse J, Sabato V, Aberer E, Al-Ali HK, Morren MA, Varkonyi J, Zink A, Niedoszytko M, Niederwieser D, Malcovati L, Reiter A, Kennedy V, Gotlib J, Lortholary O, Hermine O, Arock M, Kluin-Nelemans H, Sperr WR: The Data Registry of the European Competence Network on Mastocytosis (ECNM): Set Up, Projects, and Perspectives. J Aller Cl Imm-pract, 2019; 7 (1): 81-87. : http://dx.doi.org/10.1016/j.jaip.2018.09.024
  • von Spee-Mayer C, Koemm V, Wehr C, Goldacker S, Kindle G, Bulashevska A, Proietti M, Grimbacher B, Ehl S, Warnatz K: Evaluating laboratory criteria for combined immunodeficiency in adult patients diagnosed with common variable immunodeficiency. Clin Immunol, 2019; 203: 59-62. : http://dx.doi.org/10.1016/j.clim.2019.04.001
  • Waterhouse M, Pfeifer D, Duque-Afonso J, Follo M, Duyster J, Depner M, Bertz H, Finke J: Droplet digital PCR for the simultaneous analysis of minimal residual disease and hematopoietic chimerism after allogeneic cell transplantation. Clin Chem Lab Med, 2019; 57 (5): 641-647. : http://dx.doi.org/10.1515/cclm-2018-0827
  • Weishaupl D, Schneider J, Peixoto Pinheiro B, Ruess C, Dold SM, von Zweydorf F, Gloeckner CJ, Schmidt J, Riess O, Schmidt T: Physiological and pathophysiological characteristics of ataxin-3 isoforms. J Biol Chem, 2019; 294 (2): 644-661. : http://dx.doi.org/10.1074/jbc.RA118.005801
  • Wolff D, Hilgendorf I, Wagner-Drouet E, Jedlickova Z, Ayuk F, Zeiser R, Schafer-Eckart K, Gerbitz A, Stadler M, Klein S, Middeke JM, Lawitschka A, Winkler J, Halter J, Holler E, Kobbe G, Stelljes M, Ditschkowski M, Greinix H: Changes in Immunosuppressive Treatment of Chronic Graft-versus-Host Disease: Comparison of 2 Surveys within Allogeneic Hematopoietic Stem Cell Transplant Centers in Germany, Austria, and Switzerland. Biol Blood Marrow Tr, 2019; 25 (7): 1450-1455. : http://dx.doi.org/10.1016/j.bbmt.2019.03.003
  • Yu C, Gorantla SP, Muller-Rudorf A, Muller TA, Kreutmair S, Albers C, Jakob L, Lippert LJ, Yue Z, Engelhardt M, Follo M, Zeiser R, Huber TB, Duyster J, Illert AL: Phosphorylation of Beclin-1 by BCR-ABL suppresses autophagy in chronic myeloid leukemia. Haematologica, 2019. : http://dx.doi.org/10.3324/haematol.2018.212027 (in Druck)
  • Zeiser R: Advances in understanding the pathogenesis of graft-versus-host disease. Brit J Haematol, 2019. : http://dx.doi.org/10.1111/bjh.16190 (in Druck)
Reviews/Übersichtsartikel in wissenschaftlichen Fachzeitschriften:
  • Kohler N, Zeiser R: Intestinal Microbiota Influence Immune Tolerance Post Allogeneic Hematopoietic Cell Transplantation and Intestinal GVHD. Front Immunol, 2019; 9: 3179-3179. : http://dx.doi.org/10.3389/fimmu.2018.03179
  • Prestipino A, Zeiser R: Clinical implications of tumor-intrinsic mechanisms regulating PD-L1. Sci Transl Med, 2019; 11 (478) (online). : http://dx.doi.org/10.1126/scitranslmed.aav4810
  • Scherer F: Capturing Tumor Heterogeneity and Clonal Evolution by Circulating Tumor DNA Profiling. Recent Results Cancer Res, 2019; 215: 213-230. : http://dx.doi.org/10.1007/978-3-030-26439-0_11
  • Zeiser R, Beelen DW, Bethge W, Bornhauser M, Bug G, Burchert A, Christopeit M, Duyster J, Finke J, Gerbitz A, Klusmann JH, Kobbe G, Lubbert M, Muller-Tidow C, Platzbecker U, Rosler W, Sauer M, Schmid C, Schroeder T, Stelljes M, Kroger N, Muller LP: Biology-Driven Approaches to Prevent and Treat Relapse of Myeloid Neoplasia after Allogeneic Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Tr, 2019; 25 (4): e128-e140. : http://dx.doi.org/10.1016/j.bbmt.2019.01.016
  • Zeiser R, Vago L: Mechanisms of immune escape after allogeneic hematopoietic cell transplantation. Blood, 2019; 133 (12): 1290-1297. : http://dx.doi.org/10.1182/blood-2018-10-846824
Sonstige Publikationen:
  • Heumuller A, Wehrle J, Stosch J, Niemoller C, Bleul S, Waterhouse M, Uhl D, Metzeler KH, Lubbert M, Duyster J, Finke J, Becker H: Clonal hematopoiesis of indeterminate potential in older patients having received an allogeneic stem cell transplantation from young donors. Bone Marrow Transpl, 2019. : http://dx.doi.org/10.1038/s41409-019-0575-4 (in Druck)

Besondere wissenschaftliche Aktivitäten

Preise / Ehrungen:
  • Dr. Verena Klämbt: Albrecht-Fleckenstein-Preis, für Ihre Promotionsarbeit (AG Zeiser), 22.08.2016.

Abschlussarbeiten